Life Science REIT PLC Cash Flow Reinvestment Rate
Life Science REIT PLC cash flow reinvestment rate. Life Science REIT PLC (LABS) has a Cash Flow Reinvestment Rate of 6.06x as of June 2025, reinvesting GBX5.81 Million (capex GBX5.81 Million ) from operating cash flow of GBX958.00K. Explore LABS cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Life Science REIT PLC (2021–2024)
Cash flow reinvestment rate of Life Science REIT PLC from 2021 to 2024. Historical reinvestment intensity for Life Science REIT PLC across 3 annual periods. Explore LABS capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Life Science REIT PLC Cash Flow Reinvestment Rate by Year (2021–2024)
Life Science REIT PLC cash flow reinvestment rate by year from 2021 to 2024. Year-by-year capital reinvestment analysis for Life Science REIT PLC. For the full cash flow conversion analysis, see LABS cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.76x | GBX35.63 Million | GBX12.92 Million | GBX19.28 Million | ▼ -41.1% |
| 2023 | 4.69x | GBX35.68 Million | GBX7.62 Million | GBX24.03 Million | ▼ -91.2% |
| 2021 | 53.46x | GBX189.16 Million | GBX3.54 Million | GBX7.64 Million | — |